For over three decades, Midas Pharma has been sourcing and supplying intermediates and providing related services. We offer a broad range of intermediates including industrial reactives, fine chemicals as well as critical and advanced intermediates.
Our activities are continuously updated to meet market needs and are not limited to the pharmaceutical industry. Our offerings are customized to also comply with requirements of the agro, perfumery and other industries.

Complementary Services

Custom Synthesis Services — for non-sourceable and hard to find APIs/IMs, our experts can tailor a synthesis that satisfies any technological requirement. More

Intellectual Property Services — assure the successful course of proprietary development projects. They evaluate the intellectual property (IP) situation of Routes of Synthesis (RoS), clarify the legal status of EP patents (EPO), and do freedom to operate analysis (FTO) and associated reports. More

Quality Management Services — assess supplier and sites qualifications supporting all quality questions regarding GMP and N-1 intermediates. More

Regulatory Services — compile regulatory documentation required for GMP and N-1 Intermediates and provide crucial assistance during registration procedures. More


With a wealth of experience and expertise in sourcing and supplying intermediates, as well as providing related services, we offer comprehensive solutions to meet your needs.

Please contact:
Dr. Peter Markus
This email address is being protected from spambots. You need JavaScript enabled to view it.
Diese Website verwendet Cookies. Cookies sind kleine Textdateien, die dabei helfen, die Website zu optimieren. Mit der Nutzung der Website stimmen Sie der Verwendung von Cookies zu. Nähere Informationen zu Cookies finden Sie in unserer Datenschutzerklärung.
This website uses cookies. Cookies are small text files which help us to optimize this website. By using this website you agree to the use of cookies. More information concerning cookies is available in the privacy statement.